Royalty Pharma plc logo RPRX - Royalty Pharma plc

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 11
HOLD 0
SELL 0
STRONG
SELL 0
| PRICE TARGET: $53.75 DETAILS
HIGH: $63.00
LOW: $45.00
MEDIAN: $53.50
CONSENSUS: $53.75
DOWNSIDE: 1.38%

Profitability Ratios

Ratio Value
GP Margin 100.0%
EBIT Margin 68.6%
EBITDA Margin 68.8%
Operating Margin 65.6%
Pretax Margin 55.7%
Cont. Ops Margin 55.7%
Net Margin 32.4%
Bottom Line Margin 42.3%

Liquidity Ratios

Ratio Value
Current Ratio 0.97
Quick Ratio 0.97
Solvency Ratio 0.078
Cash Ratio 0.97

Valuation Ratios

Ratio Value
Price/Earnings
21.65
Hist. avg: 21.8
Peers avg: 32.5
PEG Ratio 1.01
Forward PEG 1.01
Price/Book 2.58
Price/Sales 7.02
Price/FCF 6.70
Price/Op Cash Flow 6.70

Debt Ratios

Ratio Value
Debt/Assets 0.4562
Debt/Equity 1.3820
Debt/Capital 0.5802
Long-Term Debt/Capital 0.5696
Financial Leverage 3.03

Cash Flow Ratios

Ratio Value
Working Capital Turnover 8.95
Operating Cash Flow Ratio 3.914
Operating Cash Flow/Sales 104.7%
Free Cash Flow/Operating Cash Flow 100.0%

Coverage Ratios

Ratio Value
Debt Service Coverage 2.38
Interest Coverage 5.0689
Short-Term Operating Cash Flow Coverage 6.55
Operating Cash Flow Coverage 0.28
Capital Expenditure Coverage 0.00
Dividend + Capital Expenditure Coverage 6.58

Dividend Ratios

Ratio Value
Payout Ratio 49.0634%
Dividend Yield 2.2666%
Dividend Yield % 2.2666%
Dividend Per Share 0.8758

Per Share Ratios

Ratio Value
Revenue/Share 5.51
EPS 1.785
Debt/Share 21.4375
Cash/Share 1.48
Book Value/Share 22.49
Tangible BV/Share 20.35
Equity/Share 15.00
Operating Cash Flow/Share 5.765
Capital Expenditure/Share 0.000
FCF/Share 5.765

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 0.582
Earnings Before Tax/EBIT 0.849
Price/Fair Value 2.58
Debt/Market Cap 0.5364
Effective Tax Rate 0.0%
Enterprise Value Multiple 15.30